Estimating the burden of SARS-CoV-2 in France
Open accessPublished version of a preprint
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
COVID-19 pandemic in France: Coronavirus disease 2019 (COVID-19) exacted a heavy toll in France during March and April 2020. Quarantine measures were effective in reducing transmission by 84%, and some relaxation of social isolation was expected in May. Salje et al. fit transmission models for the epidemic in France to hospital admissions. The authors forecast that 2.9 million people will have been infected by 11 May, representing 4.4% of the population—a value inadequate for herd immunity. Daily critical care hospitalizations should reduce from several hundreds to tens of cases, but control will remain a delicate balancing act. Any relaxation of lockdown in France will have to be carefully controlled and monitored to avoid undermining more optimistic forecasts. Science , this issue p. 208
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several studies have estimated cumulative infections in select countries at specific points in time.6, 7, 8, 9”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Diekmann, O., Heesterbeek, J. A. P., & Metz, J. A. J. (1990) · Journal of Mathematical Biology · doi:10.1007/bf00178324 · Cited by 5,091
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
The effect of human mobility and control measures on the COVID-19 epidemic in China
Kraemer, M. U. G., Yang, C.-H., Gutierrez, B., Wu, C.-H., Klein, B., Pigott, D. M., Open COVID-19 Data Working Group, du Plessis, L., Faria, N. R., Li, R., et al. (2020) · Science · doi:10.1126/science.abb4218 · Cited by 2,950
Mizumoto, K., Kagaya, K., Zarebski, A., & Chowell, G. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.10.2000180 · Cited by 2,276
Tian, H., Liu, Y., Li, Y., Wu, C.-H., Chen, B., Kraemer, M. U. G., Li, B., Cai, J., Xu, B., Yang, Q., et al. (2020) · Science · doi:10.1126/science.abb6105 · Cited by 2,010
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Self-citationLinton, N., Kobayashi, T., Yang, Y., Hayashi, K., Akhmetzhanov, A., Jung, S.-M., Yuan, B., Kinoshita, R., & Nishiura, H. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020538 · Cited by 1,361
How generation intervals shape the relationship between growth rates and reproductive numbers
Wallinga, J., & Lipsitch, M. (2007) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2006.3754 · Cited by 1,213
Cited by
Items 301–400 of 1,001
Casini, L., & Roccetti, M. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-051458 · Cited by 28
Chen, S., Flegg, J. A., White, L. J., & Aguas, R. J. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009436 · Cited by 29
COVID-19: risk factors for severe cases of the Delta variant
Hu, K., Liu, L., Liang, Y., Shao, X., Hu, Z., Luo, H., & Lei, M. (2021) · Aging · doi:10.18632/aging.203655 · Cited by 35
Dias, A. C., Scavarda, A., Silveira, H., Scavarda, L. F., & Kondamareddy, K. K. (2021) · Sustainability · doi:10.3390/su132112197 · Cited by 32
Two distinct immunopathological profiles in autopsy lungs of COVID-19Preprint
Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M. J., Frank, A., Zsikla, V., et al. (2020) · medRxiv · doi:10.1101/2020.06.17.20133637 · Cited by 29
GS-5734: a potentially approved drug by FDA against SARS-Cov-2
Wang, Z., & Yang, L. (2020) · New Journal of Chemistry · doi:10.1039/d0nj02656e · Cited by 28
Kuster, A. C., & Overgaard, H. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248176 · Cited by 30
Fiore, V. G., DeFelice, N., Glicksberg, B. S., Perl, O., Shuster, A., Kulkarni, K. R., O’Brien, M., Pisauro, M. A., Chung, D., & Gu, X. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247614 · Cited by 28
Bellizzi, S., Alsawalha, L., Ali, S. S., Sharkas, G. F., Muthu, N., Ghazo, M., Aly, E., Rashidian, A., Ariqi, L. A., Hayajneh, W. A., et al. (2021) · One Health · doi:10.1016/j.onehlt.2021.100292 · Cited by 27
Lockdown impact on age-specific contact patterns and behaviours, France, April 2020
Bosetti, P., Huynh, B.-T., Abdou, A. Y., Sanchez, M., Eisenhauer, C., Courtejoie, N., Accardo, J., Salje, H., Guillemot, D., Moslonka‐Lefebvre, M., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.48.2001636 · Cited by 34
Self-citationden Bulck, S. V., Crèvecoeur, J., Aertgeerts, B., Delvaux, N., Neyens, T., Pottelbergh, G. V., Coursier, P., & Vaes, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271049 · Cited by 30
Álamo, T., Reina, D. G., & Millán, P. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2006.01731 · Cited by 52
Comparative evaluation of behavioral epidemic models using COVID-19 data
Gozzi, N., Perra, N., & Vespignani, A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2421993122 · Cited by 41
Marin-Garcia, J. A., Garcia-Sabater, J. P., Ruiz, A. B., Maheut, J., & Sabater, J. J. G. (2020) · Journal of Industrial Engineering and Management · doi:10.3926/jiem.3190 · Cited by 29
Social heterogeneity and the COVID-19 lockdown in a multi-group SEIR model
Jean Dolbeault, A., & Turinici, G. (2021) · Computational and Mathematical Biophysics · doi:10.1515/cmb-2020-0115 · Cited by 27
The scale and dynamics of COVID-19 epidemics across Europe
Dye, C., Cheng, R. C. H., Dagpunar, J. S., & Williams, B. G. (2020) · Royal Society Open Science · doi:10.1098/rsos.201726 · Cited by 32
Pandemic economics: optimal dynamic confinement under uncertainty and learning
Gollier, C. (2020) · The Geneva Risk and Insurance Review · doi:10.1057/s10713-020-00052-1 · Cited by 27
Abry, P., Pustelnik, N., Roux, S. G., Jensen, P., Flandrin, P., Gribonval, R., Lucas, C.-G., Guichard, É., Borgnat, P., Garnier, N., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237901 · Cited by 36
Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population
Lapidus, N., Paireau, J., Lévy-Bruhl, D., de Lamballerie, X. N., Severi, G., Touvier, M., Zins, M., Cauchemez, S., Carrat, F., & the SAPRIS-SERO study group (2020) · Infectious Diseases Now · doi:10.1016/j.idnow.2020.12.007 · Cited by 32
Self-citationVoiriot, G., Dorgham, K., Bachelot, G., Fajac, A., Morand‐Joubert, L., Parizot, C., Gerotziafas, G., Farabos, D., Trugnan, G., Eguether, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-13179-0 · Cited by 30
Canadians’ trust in government in a time of crisis: Does it matter?
Herati, H., Burns, K. E., Nascimento, M., Brown, P. R., Calnan, M., Dubé, È., Ward, P., Filice, E., Rotolo, B., Ike, N., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290664 · Cited by 29
Modelling the initial epidemic trends of COVID-19 in Italy, Spain, Germany, and France
Wang, K., Ding, L., Yan, Y., Dai, C., Qu, M., Jiayi, D., & Hao, X. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241743 · Cited by 27
Akamatsu, T., NAGAE, T., Osawa, M., Satsukawa, K., Sakai, T., & MIZUTANI, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-81630-9 · Cited by 32
Bosetti, P., Kiem, C. T., Andronico, A., Vittoria Colizza, A., Yazdanpanah, Y., Fontanet, A. L., Benamouzig, D., & Cauchemez, S. (2022) · BMC Medicine · doi:10.1186/s12916-022-02235-1 · Cited by 24
Self-citationShimul, S. N., Alradie-Mohamed, A., Kabir, R., Al-Mohaimeed, A., & Mahmud, I. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256958 · Cited by 26
The impact of lockdown strategies targeting age groups on the burden of COVID-19 in France
Roche, B., Garchitorena, A., & Roiz, D. (2020) · Epidemics · doi:10.1016/j.epidem.2020.100424 · Cited by 30
Tuells, J., Egoavil, C. M., Pena, M. Á., Montagud, A. C., Penadés, E. M., Caballero, P., Zapater, P., Puig‐Barberà, J., & Sánchez, J. A. H. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041908 · Cited by 30
Optimal lockdowns for COVID‐19 pandemics: Analyzing the efficiency of sanitary policies in Europe
Gallic, E., Lubrano, M., & Michel, P. (2021) · Journal of Public Economic Theory · doi:10.1111/jpet.12556 · Cited by 25
Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2
de Cellès, M. D., Casalegno, J., Lina, B., & Opatowski, L. (2021) · PeerJ · doi:10.7717/peerj.12566 · Cited by 27
Self-citationPublic health ethics: critiques of the “new normal”
Jamrozik, E. (2022) · Bioethics News · doi:10.1007/s40592-022-00163-7 · Cited by 33
A real-time regional model for COVID-19: Probabilistic situational awareness and forecasting
Engebretsen, S., Palomares, A. D.-L., Rø, G., Kristoffersen, A. B., Lindstrøm, J. C., Engø‐Monsen, K., Kamineni, M., Chan, L. Y. H., Dale, Ø., Midtbø, J. E., et al. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010860 · Cited by 31
Exploring the Landscape of Fractional-Order Models in Epidemiology: A Comparative Simulation Study
Agarwal, R., Airan, P., & Agarwal, R. P. (2024) · Axioms · doi:10.3390/axioms13080545 · Cited by 24
Yang, Q., Li, J., Zhang, Z., Wu, X., Liao, T., Yu, S., You, Z., Hou, X., Ye, J., Liu, G., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06478-w · Cited by 27
Acute-to-Chronic Glycemic Ratio as a Predictor of COVID-19 Severity and Mortality
Ramón, J., Llauradó, G., Güerri‐Fernández, R., Climent, E., Ballesta, S., Benaiges, D., López-Montesinos, I., Navarro, H., Fernández, N., Carrera, M. J., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1321 · Cited by 25
Mass SARS-CoV-2 serological screening, a population-based study in the Principality of Andorra
Royo, C., Vilanova, D., Lopez, J., Arroyo, V., Pons, M., Francisco, G., Carrasco, M. G., Piqué, J. M., Sanz, S., Dobaño, C., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100119 · Cited by 22
A particle swarm optimization approach for predicting the number of COVID-19 deaths
Haouari, M., & Mhiri, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-96057-5 · Cited by 27
Designing an optimal sequence of non‐pharmaceutical interventions for controlling COVID-19
Biswas, D., & Alfandari, L. (2022) · European Journal of Operational Research · doi:10.1016/j.ejor.2022.03.052 · Cited by 28
Pandemic lockdown, isolation, and exit policies based on machine learning predictions
Evgeniou, T., Fekom, M., Ovchinnikov, A. S., Porcher, R., Pouchol, C., & Vayatis, N. (2022) · Production and Operations Management · doi:10.1111/poms.13726 · Cited by 22
Ma, S., Damfo, S. A., Lou, J., Pinotsis, N., Bowler, M. W., Haider, S. M., & Kozielski, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012448 · Cited by 22
Paireau, J., Charpignon, M., Larrieu, S., Calba, C., Hozé, N., Boëlle, P., Thiébaut, R., Prague, M., & Cauchemez, S. (2023) · BMC Infectious Diseases · doi:10.1186/s12879-023-08106-1 · Cited by 25
Self-citationCOVID‐19 and its Severity in Bariatric Surgery‐Operated Patients
Lassen, P. B., Poitou, C., Genser, L., Marchelli, F., Aron‐Wisnewsky, J., Ciangura, C., Jacques, F., Moreau, P., NutriOmics investigators, Oppert, J., et al. (2020) · Obesity · doi:10.1002/oby.23026 · Cited by 26
Skladaný, Ľ., Koller, T., Selčanová, S. A., Vnenčáková, J., Janceková, D., Ďurajová, V., Lafférs, L., Juraj, S. V. A. C., Janickova, K., Palkovič, M., et al. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00231-8 · Cited by 23
Analysis of the Tradeoff Between Health and Economic Impacts of the Covid-19 Epidemic
Lasaulce, S., Zhang, C., Varma, V. S., & Morărescu, I. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.620770 · Cited by 26
Hupert, N., Marín‐Hernández, D., Gao, B., Aguas, R. J., & Nixon, D. F. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2025448119 · Cited by 27
Impact of the first wave of the COVID-19 pandemic on French Health students
Rolland, F., Frajerman, A., Falissard, B., Bertschy, G., Diquet, B., & Marra, D. (2022) · L Encéphale · doi:10.1016/j.encep.2021.12.004 · Cited by 26
Prioritizing COVID-19 vaccination efforts and dose allocation within Madagascar
Rasambainarivo, F., Ramiadantsoa, T., Raherinandrasana, A. H., Randrianarisoa, S., Rice, B. L., Evans, M., Roche, B., Randriatsarafara, F. M., Wesolowski, A., & Metcalf, C. J. E. (2022) · BMC Public Health · doi:10.1186/s12889-022-13150-8 · Cited by 22
Optimal Timing of Interventions during an Epidemic
Huberts, N. F. D., & Thijssen, J. (2020) · European Journal of Operational Research · doi:10.1016/j.ejor.2022.06.034 · Cited by 29
Modelling COVID-19 Contagion: Risk Assessment and Targeted Mitigation Policies
Cont, R., Kotlicki, A., & Xu, R. (2020) · Royal Society Open Science · doi:10.1098/rsos.201535 · Cited by 22
Pinotti, F., Wikramaratna, P. S., Obolski, U., Paton, R. S., Damineli, D. S. C., Alcântara, L. C. J., Giovanetti, M., Gupta, S., & Lourenço, J. (2021) · BMC Medicine · doi:10.1186/s12916-020-01887-1 · Cited by 20
Gil‐Jardine, C., Chenais, G., Pradeau, C., Tentillier, E., Revel, P., Combes, X., Galinski, M., Tellier, É., & Lagarde, E. (2021) · Scandinavian Journal of Trauma Resuscitation and Emergency Medicine · doi:10.1186/s13049-021-00862-w · Cited by 28
Death and Destitution: The Global Distribution of Welfare Losses from the COVID-19 Pandemic
Ferreira, F. H. G., Sterck, O. C., Mahler, D. G., & Decerf, B. (2021) · LSE Public Policy Review · doi:10.31389/lseppr.34 · Cited by 21
de Laval, F., Grosset-Janin, A., Delon, F., Allonneau, A., Tong, C., Letois, F., Couderc, A., Sanchez, M.-A., Destanque, C., Biot, F., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06166-9 · Cited by 25
Li, R., Metcalf, C. J. E., Stenseth, N. C., & Bjørnstad, O. N. (2021) · Science Advances · doi:10.1126/sciadv.abf9040 · Cited by 19
Epidemic management and control through risk-dependent individual contact interventions
Schneider, T., Dunbar, O. R. A., Wu, J., Böttcher, L., Burov, D., Garbuno-Iñigo, A., Wagner, G. L., Pei, S., Daraio, C., Ferrari, R., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010171 · Cited by 26
Launay, T., Bardoulat, I., Lemaître, M., Blanchon, T., & Fardet, L. (2021) · Clinical and Experimental Dermatology · doi:10.1111/ced.15054 · Cited by 25
Early chains of transmission of COVID-19 in France, January to March 2020
Paireau, J., Mailles, A., Eisenhauer, C., de Laval, F., Delon, F., Bosetti, P., Salje, H., Pontiès, V., & Cauchemez, S. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.6.2001953 · Cited by 24
Self-citationYusefi, A. R., Davarani, E. R., Daneshi, S., Bastani, M., Mehralian, G., & Bastani, P. (2022) · BMC Geriatrics · doi:10.1186/s12877-022-03344-5 · Cited by 34
Collin, A., Hejblum, B. P., Vignals, C., Lehot, L., Thiébaut, R., Moireau, P., & Prague, M. (2023) · The International Journal of Biostatistics · doi:10.1515/ijb-2022-0087 · Cited by 31
Performance of serum apolipoprotein-A1 as a sentinel of Covid-19
Poynard, T., Deckmyn, O., Rudler, M., Peta, V., Ngo, Y., Vautier, M., Akhavan, S., Cálvez, V., Franc, C., Castille, J. M., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242306 · Cited by 21
Optimal intervention strategies to mitigate the COVID-19 pandemic effects
Kasis, A., Timotheou, S., Monshizadeh, N., & Polycarpou, M. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-09857-8 · Cited by 29
Roland, N., Drouin, J., Desplas, D., Cuenot, F., Dray‐Spira, R., Weill, A., & Zureik, M. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004281 · Cited by 21
Pouwels, K. B., House, T., Robotham, J. V., Birrell, P., Gelman, A., Bowers, N., Boreham, I., Thomas, H., Lewis, J., Bell, I., et al. (2020) · medRxiv · doi:10.1101/2020.07.06.20147348 · Cited by 23
Prague, M., Wittkop, L., Collin, A., Dutartre, D., Clairon, Q., Moireau, P., Thiébaut, R., & Hejblum, B. P. (2020) · medRxiv · doi:10.1101/2020.04.21.20073536 · Cited by 25
Cai, R., Novosad, P. M., Tandel, V., Asher, S., & Malani, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050920 · Cited by 21
EpiBeds: Data informed modelling of the COVID-19 hospital burden in England
Overton, C. E., Pellis, L., Stage, H. B., Scarabel, F., Burton, J., Fraser, C., Hall, I., House, T., Jewell, C., Nurtay, A., et al. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010406 · Cited by 20
Mallet, Y., Pivette, M., Revest, M., Angot, E., Valence, M., Dupin, C., Picard, N., Brelivet, G., Seyler, T., Ballet, S., et al. (2021) · Food and Environmental Virology · doi:10.1007/s12560-021-09500-1 · Cited by 20
Buchwald, P. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.898035 · Cited by 20
Correlations of mobility and Covid-19 transmission in global data
BERGMAN, N. K., & Fishman, R. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279484 · Cited by 23
Verification results for age-structured models of economic–epidemics dynamics
Fabbri, G., Gozzi, F., & Zanco, G. (2020) · Journal of Mathematical Economics · doi:10.1016/j.jmateco.2020.102455 · Cited by 21
SARS-CoV-2 challenge studies: ethics and risk minimisation
Bull, S., Jamrozik, E., Binik, A., & Parker, M. J. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106504 · Cited by 23
Serologic response to SARS-CoV-2 in an African population
Fai, K. N., Corine, T. M., Bebell, L. M., Akenji, B., Nguimbis, B., Nsaibirni, R., Mbarga, N. F., Eteki, L., Nikolay, B., Essomba, R. G., et al. (2021) · Scientific African · doi:10.1016/j.sciaf.2021.e00802 · Cited by 20
Vallée, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.818989 · Cited by 24
Mosbah, H., Coupaye, M., Jacques, F., Tauber, M., Clément, K., Oppert, J., & Poitou, C. (2021) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-021-01833-1 · Cited by 19
Hubiche, T., Phan, A., Leducq, S., Rapp, J., Fertitta, L., Aubert, H., Barbarot, S., Chiavérini, C., Giraudeau, B., Lasek, A., et al. (2021) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2020.11.005 · Cited by 22
Marra, V., & Quartin, M. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.08.016 · Cited by 19
A Review of Different Vaccines and Strategies to Combat COVID-19
Sabitha, S., Shobana, N., Prakash, P., Padmanaban, S., Sathiyasree, M., Saigeetha, S., Chakravarthi, S., Uthaman, S., Park, I., & Samrot, A. V. (2022) · Vaccines · doi:10.3390/vaccines10050737 · Cited by 30
van der Sluijs, K. M., Bakker, E. A., Schuijt, T. J., Joseph, J., Kavousi, M., Geersing, G., Rutten, F. H., Hartman, Y., Thijssen, D. H. J., & Eijsvogels, T. M. H. (2022) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00335.2022 · Cited by 22
Non-Pharmacologic Interventions in COVID-19 Pandemic Management; a Systematic Review.
Etemad, K., Mohseni, P., Shojaei, S., Mousavi, S. A., Taherkhani, S., Atatalab, F. F., Ghajari, H., Nazari, S. S. H., Karami, M., Izadi, N., et al. (2023) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v11i1.1828 · Cited by 19
Inference of epidemic dynamics in the COVID-19 era and beyond
Cori, A., & Kucharski, A. J. (2024) · Epidemics · doi:10.1016/j.epidem.2024.100784 · Cited by 20
SARS-CoV-2: Virology, epidemiology, immunology and vaccine development
Baay, M. F. D., Lina, B., Fontanet, A. L., Marchant, A., Saville, M. K., Sabot, P., DUCLOS, P. J., Vandeputte, J., & Neels, P. (2020) · Biologicals · doi:10.1016/j.biologicals.2020.06.005 · Cited by 19
Self-citationWhy continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
Steel, R. K., Buchak, L., & Eyal, N. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106501 · Cited by 19
Foutel‐Rodier, F., Blanquart, F., Courau, P., Czuppon, P., Duchamps, J., Gamblin, J., Kerdoncuff, É., Kulathinal, R. J., Régnier, L., Vuduc, L., et al. (2022) · Journal of Mathematical Biology · doi:10.1007/s00285-022-01794-4 · Cited by 19
Khrennikov, A. Y., & Klaudia Oleschko, L. (2020) · Entropy · doi:10.3390/e22090931 · Cited by 22
Outcomes of Patients with COPD Hospitalized for Coronavirus Disease 2019
Neira, D. A. P., Watts, A., Seashore, J., Duarte, A. G., Nishi, S. P. E., Polychronopoulou, E., Kuo, Y., Baillargeon, J., & Sharma, G. (2021) · Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation · doi:10.15326/jcopdf.2021.0245 · Cited by 19
Early phylodynamics analysis of the COVID-19 epidemic in France
Danesh, G., Elie, B., Michalakis, Y., Sofonea, M. T., Bal, A., Behillil, S., Destras, G., Boutolleau, D., Burrel, S., Marcelin, A., et al. (2021) · Peer Community Journal · doi:10.24072/pcjournal.40 · Cited by 23
Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in Adults in Madrid, Spain
Soriano, V., Meirino, R. M., Corral, O. J., & Guallar, M. P. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa769 · Cited by 19
Dimeglio, C., Hérin, F., Miédougé, M., Cambus, J., Abravanel, F., Mansuy, J., Soulat, J.-M., & Izopet, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.09.035 · Cited by 21
Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France
Gégout‐Petit, A., Jeulin, H., Legrand, K., Jay, N., Bochnakian, A., Vallois, P., Schvoerer, É., & Guillemin, F. (2021) · Viruses · doi:10.3390/v13061076 · Cited by 20
Association between the Human Development Index and Confirmed COVID-19 Cases by Country
Heo, M.-H., Kwon, Y. D., Cheon, J., Kim, K.-B., & Noh, J. (2022) · Healthcare · doi:10.3390/healthcare10081417 · Cited by 20
Camacho-Moll, M. E., Mata-Tijerina, V., Silva-Ramírez, B., Peñuelas-Urquides, K., González-Escalante, L. A., Escobedo-Guajardo, B. L., Luna, J. E. C., Corrales-Pérez, R., García, S. G., & de León, M. B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072676 · Cited by 22
Vahdani, B., Mohammadi, M., Thevenin, S., Meyer, P. E., & Dolgui, A. B. (2023) · Omega · doi:10.1016/j.omega.2023.102909 · Cited by 19
Rasambainarivo, F., Rasoanomenjanahary, A., Rabarison, J. H., Ramiadantsoa, T., Ratovoson, R., Randremanana, R. V., Randrianarisoa, S., Rajeev, M., Masquelier, B., Héraud, J., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.11.182 · Cited by 18
Singh, R. B., Halabi, G., Fatima, G., Rai, R. H., Tarnava, A., & LeBaron, T. W. (2021) · Clinical Case Reports · doi:10.1002/ccr3.5039 · Cited by 19
Ouardighi, F. E., Khmelnitsky, E., & SETHI, S. P. (2020) · Production and Operations Management · doi:10.1111/poms.13641 · Cited by 26
Chapman, L. A. C., Barnard, R. C., Russell, T. W., Abbott, S., van Zandvoort, K., Davies, N. G., & Kucharski, A. J. (2022) · Eurosurveillance · doi:10.2807/1560-7917.es.2022.27.1.2101038 · Cited by 16
Monitoring of patients with systemic lupus erythematosus during the COVID-19 outbreak
Holubar, J., Quintrec, M. L., Letaief, H., Faillie, J. L., Pers, Y., & Jørgensen, C. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-217919 · Cited by 18
Anatomy of digital contact tracing: role of age, transmission setting, adoption and case detectionPreprint
López, J. A. M., García, B. A., Bentkowski, P., Bioglio, L., Pinotti, F., Boëlle, P., Barrat, A., Vittoria Colizza, A., & Poletto, C. (2020) · medRxiv · doi:10.1101/2020.07.22.20158352 · Cited by 18
Davies, H. T. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2021-107709 · Cited by 18
Determinants of SARS-CoV-2 transmission to guide vaccination strategy in an urban area
Brüningk, S. C., Klatt, J., Stange, M., Mari, A., Brunner, M., Roloff, T. C., Seth-Smith, H. M. B., Schweitzer, M., Leuzinger, K., Søgaard, K. K., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac002 · Cited by 22
Strategies for COVID-19 vaccination under a shortage scenario: a geo-stochastic modelling approach
Barreiro, N. L., Ventura, C. I., Govezensky, T., Núñez, M., Bolcatto, P. G., & Barrio, R. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-05481-8 · Cited by 17
Metadata
- Authors
- Salje, H., Tran Kiem, C., Lefrancq, N., Courtejoie, N., Bosetti, P., Paireau, J., Andronico, A., Hozé, N., Richet, J., Dubost, C.-L., Le Strat, Y., Lessler, J., Levy-Bruhl, D., Fontanet, A., Opatowski, L., Boelle, P.-Y., & Cauchemez, S.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France.
- Ministère des Solidarités et de la Santé (FR)
- Santé Publique France, French National Public Health Agency, Saint-Maurice, France.
- Johns Hopkins University (US)
- Conservatoire National des Arts et Métiers (FR)
- Inserm (FR)
- Institut Pierre Louis d’Epidémiologie et de Santé Publique, Sorbonne Université, INSERM, Paris, France.
- Corresponding author
- Cauchemez, Simon
- ORCID
- Venue
- Science
- Published
- 2020-07-10
- Volume
- 369
- Issue
- 6500
- Pages
- 208-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC7223792
- OpenAlex
- W3025090814
- Cited by
- 1,038
- References
- 30
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 50 · 2023: 90 · 2022: 171 · 2021: 378 · 2020: 303
- FWCI
- 37.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Science (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion, cc-by-nc)
- Funders
- H2020 European Research Council (804744)
- ANR (ANR-10-LABX-62-IBEID)
- INCEPTION (PIA/ANR-16-CONV-0005)
- Santé Publique France
- European Union RECOVER
- University of Cambridge COVID-19 Rapid Response Grant
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, hospitalization rates, mortality rates, lockdown, reproduction number, herd immunity, age and sex differences, intensive care, second wave, France
- MeSH terms
- COVID-19, Adolescent, Adult, Aged, Aged, 80 and over, Critical Care, Female, France, Hospitalization, Humans, Immunity, Male, Middle Aged, Pneumonia, Viral, Quarantine, Cost of Illness, Coronavirus Infections, Severe acute respiratory syndrome-related coronavirus, Young Adult, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.